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 gone dental restoration with osseointegrated implants
and can tolerate a regular diet. Five additional patients
are awaiting implant placement.
For extensive palatomaxillary defects, obturator re-
habilitation may not be an option because of overly
heavy prostheses with poor retention, particularly in
edentulous patients.2,3 Microvascular free flaps have
largely replaced local and regional flaps, which are
limited by their small size, short pedicle length, and
frequent need for staging of procedures.4 Although a
number of free flaps have been suggested,4,5 a standard
reconstructive technique has not emerged, partially
because none of these flaps resembles the complex
shape of the maxillae in their native form.
Our technique for shaping the fibula osteocutane-
ous free flap mimics the configuration of the midface,
restoring midfacial height, width, and projection; pre-
vents palatal incompetence; and can accommodate os-
seointegrated implants for dental restoration. We rec-
ommend this reconstructive technique for all patients
with extensive unilateral or bilateral maxillectomy de-
fects, as consistently good aesthetic and functional re-
sults can be achieved with minimal morbidity in ap-
propriate surgical candidates.
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Acute Pain Management during Facial Injection
of Botulinum Toxin: An Evidence-Based
Systematic Review
Sir:
Botulinum toxin injection is one of the commonestprocedures in plastic surgery, with the American
Society of Plastic Surgeons’ statistics review for 2007
reporting a 7-year 488 percent increase in the number
of procedures performed.1 Indications for toxin injec-
tion have also increased substantially. Despite this huge
popularity, several authors2 have identified pain as a
common significant adverse event possibly resulting in
acute discomfort, reduced compliance, and therapeu-
tic failure. Some studies3 report that practitioners per-
ceive this pain as unworthy of treatment, introducing
the potential for inadequate pain management. The
increasing demand for and applications of botulinum
toxin require that the potential for inadequate pain
management is addressed.
We evaluated the current evidence to identify how
the potential for inadequate acute pain management
could be addressed in patients undergoing facial
injection of botulinum toxin with an electronic and
manual search using the search string “botulinum
AND toxin AND pain.” The electronic search in-
cluded PubMed, PubMed Central, Cochrane Data-
base of Systematic Reviews, ACP Journal Club,
Database of Abstracts of Reviews of Effects, Cochrane
Central Register of Controlled Trials, Cochrane
Methodology Register, Allied and Complementary
Medicine, CINAHL, EMBASE, and Ovid-MEDLINE
In-Process & Other NonIndexed Citations. To avoid
the language bias observed in the identified studies,
articles in English, Italian, French, and Spanish were
included. The literature identified was critically evalu-
ated based on the Rees (1997) framework for quanti-
tative research, the Critical Appraisal Skills Program’s
(2006) framework for qualitative research, and the
AGREE (2001) framework for guideline appraisal. The
“hierarchies-of-evidence” framework by Phillips et al.
(2001) was also used in the analysis. A “literature map”
of the studies appraised is shown in Figure 1.
Topical anesthetic pretreatment and toxin recon-
stitution were two identified critical areas that could
lead to inadequate acute pain management in pa-
tients undergoing facial botulinum toxin injection.
Acute pain during facial injection of botulinum toxin
is a common adverse event, and good practice re-
quires adequate pain management. It is recom-
mended that eutectic mixture of local anesthetics
cream should be applied, which has been shown to
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lead to a significant reduction in acute procedural
pain and to be preferred by patients. Addition of
nitrous oxide in oxygen may avoid the use of general
anesthetic in pediatric patients.4 The reconstituting
agent has similarly been shown to have a significant
effect on acute pain. Sterile distilled water should be
avoided because it may induce an increase in pain
perception. Ideally, normal saline– containing pre-
servative (benzyl alcohol) should be used. Based on
the evaluation of available evidence, recommenda-
tions for future practice are summarized in Table 1.
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Table 1. Summary of Evidence and
Recommendations for Future Practice Based on the
Evaluation of Available Evidence
1. Acute pain is a common adverse event during facial
injection of botulinum toxin. This should be
acknowledged by the expert community and adequately
managed.
Supporting evidence: one study at level 2c; one study
at level 4; two studies at level 5
Level 2c: Cote et al., 2005
Level 4: Elibol et al., 2007
Level 5: Wollina et al., 2005; and Caruthers et al.,
2004
2. Application of a EMLA before the procedure is
recommended to decrease acute procedural pain.
Supporting evidence: one study at level 1b; three
studies at level 4; two studies at level 5
Level 1b: Kashkouli et al., 2008
Level 4: Grande Baos., 2001; Eppley, 2004; Elibol et
al., 2007
Level 5: Carruthers et al., 2004; Wollina et al., 2005
3. The use of sterile saline-containing preservative (benzyl
alcohol) is recommended as a reconstituting agent, as it
has been noted to significantly decrease pain scores.
Supporting evidence: Two studies at level 2b; one
study at level 5
Level 2b: Van Laborde et al., 2003; Alam et al.,
2002
Level 5: Wollina, 2005
4. Sterile distilled water should be avoided as a
reconstituting agent.
Supporting evidence: one study at level 5: Yavuzer
and Demirtas, 2003
EMLA, eutectic mixture of local anesthetics.
Fig. 1. A “literature map” of the studies appraised. EMLA, eutectic mixture of local anesthetics.
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The Scapular Tip Osseous Free Flap
as an Alternative for Anterior
Mandibular Reconstruction
Sir:
Anterior segmental mandibular defects resultingfrom oncologic resection are reconstructed with
vascularized bone whenever possible. For anterior
mandibular reconstruction, the fibula free flap is the
method of choice for many surgeons. In patients who
are not candidates for a fibula free flap caused by
injury or stenosis of the lower extremity vessels, the
iliac crest free flap is advocated by some but can only
be used for defects smaller than 12 cm, and its blood
supply may also be compromised in patients with
vascular disease.
We have successfully used the scapular tip osseous
free flap for anterior mandibular reconstruction in
seven patients with peripheral vascular disease preclud-
ing fibula free flap harvest. These cases are novel in that
the inferior angle of the scapula is oriented transversely
and used to recreate the anterior mandible, obviating
the need for bony osteotomies. This flap is based on the
angular branch of the thoracodorsal artery rather than
the circumflex scapular artery, which is the traditional
blood supply of the scapular flap.1,2 The angular branch
can reliably supply up to 20 cm of bone from both the
medial and lateral scapula, compared with 12 cm of
bone in the traditional scapular flap.3 The pedicle
length can reach 17 cm if the subscapular vessels are
included, which is considerably longer than the length
of pedicle in the traditional scapular free flap (approx-
imately 6 cm).3–5
The flap is harvested with the patient in the lateral
position. The angular branch pedicle originates from
the thoracodorsal artery and lies within a submus-
cular fat pad beneath the latissimus dorsi and teres
major muscles (Fig. 1). To increase the pedicle
length and incorporate other free flaps (e.g., paras-
capular, latissimus dorsi myocutaneous, and/or ser-
ratus anterior muscle/myoosseous) as part of a chi-
mera, the dissection may extend to the subscapular
artery and vein.
The rhomboid major and teres major muscles are
partially released from the medial and lateral borders
of the scapula, respectively. The infraspinatus muscle
Fig. 1. (Left) Diagramshowing theblood supply to the scapular bone, including the angular
branch of the thoracodorsal artery. (Right) The right scapula and angular branch of the tho-
racodorsal artery exposed after retraction of the latissimus dorsi muscle inferolaterally. The
forceps points to where the angular branch vessels enter the inferior angle of the scapular
bone.
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